Home
AutoimmuneMedia
Autoimmune
-
Vasculitis Diagnosis: Microarray Testing with MosaiQ AiPlex® VAS
What is Vasculitis? Vasculitis is a group of autoimmune disorders that cause inflammation of blood vessels, which can lead to organ and tissue damage. These disorders affect vessels of different sizes (small, medium, large) and may involve multiple organs such
-
Celiac Disease Diagnostics and the Future of Autoimmune Testing
Celiac disease impacts approximately 0.7% (confirmed by biopsy) to 1.4% of the global population (based on positive results for celiac disease antibodies)[1] but despite advances in technology, it is largely underdiagnosed in the general population. Celiac disease is an autoimmune
-
Analytical Performance of a Novel, Fully Automated Multiplexed Microarray Immunoassay for the Simultaneous Detection of Anti-PR3, Anti-MPO, and Anti-GBM Autoantibodies
Autoantibodies against myeloperoxidase (MPO), proteinase 3 (PR3), and glomerular basement membrane (GBM) are critical diagnostic markers for ANCA-associated vasculitides, microscopic polyangiitis (MPA), granulomatosis with polyangiitis (GPA), eosinophilic GPA (EGPA), and anti-GBM disease.
-
Clinical Performance of a Novel, Fully Automated Multiplexed Immunoassay for the Simultaneous Detection of Anti-PR3, Anti-MPO, and Anti-GBM Autoantibodies in ANCA-Associated Vasculitis and Anti-GBM Disease
Accurate and timely detection of anti-neutrophil cytoplasmic antibodies (ANCA)—specifically against myeloperoxidase (MPO)and proteinase 3 (PR3).
-
Diabetes Diagnostics: The Need for Advanced Autoimmune Testing
The global impact of type 1 and type 2 diabetes Diabetes is one of the pressing health challenges of our time. According to the International Diabetes Federation (IDF)[1], 589 million adults worldwide are living with diabetes. This number is projected
-
Transforming Vasculitis Diagnostics: Multiplex Microarray Solutions for PR3, MPO & GBM Autoantibodies
In–vitro diagnostics (IVD) is undergoing a transformation, driven by automation and a syndromic approach enabled by multiplexing technologies. At AliveDx, we’re proud to lead this evolution with the MosaiQ AiPlex® VAS microarray, a fully automated multiplex immunoassay designed to detect
-
Unlocking Comprehensive Insights in Autoimmune Diagnostics: The Role of Anti-DFS70 Autoantibodies
Autoimmune connective tissue diseases1 (CTD) such as lupus, Sjögren’s syndrome, and systemic sclerosis present a diagnostic challenge due to overlapping symptoms and complex antibody profiles. At AliveDx, we’re committed to the challenge of simplifying that complexity through innovative in-vitro diagnostic
-
Machine learning classification based on a 15-autoantibody profile by a fully automated multiplex microarray immunoassay for autoimmune CTD diagnosis
Extended serological profiling may improve autoimmuneconnective tissue diseases (CTD) diagnosis.
-
Analytical Performance of a Novel Automated Immunoassay Microarray analyzing simultaneously 5 markers associated with Celiac Disease. ACG2024.
This study assesses the analytical performance of a novel automated immunoassay microarray for autoantibodies associated with Celiac Disease. Presented at ACG 2024.
-
Performance characteristics of Automated Immunoassay Microarray prototype detecting Centromere Protein B (CENP-B). AACC2023.
This study assesses the performance characteristics of a novel automated immunoassay microarray for detecting Anti-Centromere Protein B (CENP-B) antibodies. Presented at AACC 2023.
